Search Results
Jul 27, 2026, 10:00 ET Kessler Topaz Meltzer & Check, LLP and Bernstein Litowitz Berger & Grossmann LLP Announce a Proposed Settlement of Stockholder Class Action for Any Former Record Holders and All Beneficial Owners of The Common Stock of Continental Resources, Inc., At Any Time During The Period of October 17, 2022 Through and Including November 22, 2022
"Former Defendants" are Shelly Lambertz ("Lambertz"), John T. McNabb II ("McNabb"), Mark E. Monroe ("Monroe"), Ellis "Lon" McCain ("McCain"), Timothy G. Taylor ("Taylor"), and several trusts affiliated with the Hamm family.
More news about: Kessler Topaz Meltzer & Check LLP and Bernstein Litowitz Berger & Grossmann LLP
Jul 27, 2026, 09:00 ET GORGIE INTRODUCES CANDY APPLE, A NOSTALGIC NEW FLAVOR BRINGING A SWEET TWIST TO BETTER-FOR-YOU ENERGY
Candy Apple will be available on GETGORGIE.com and at retailers nationwide. Ahead of the nationwide release, GORGIE's loyal community and members of Club G, the brand's exclusive app-based community, received early access to Candy Apple through a special "First Sips" launch, generating excitement and authentic
More news about: GORGIE
Jul 27, 2026, 09:00 ET Synopsys and Intel Foundry Fast-Track Customer Readiness from Silicon to Systems on Intel 14A
enabling multi-die designsBroad IP portfolio for faster time-to-tapeout: Interface and Foundation IP for Intel 14A — including PCIe 7.0, 224G SerDes, USB 4 and eUSB reduce integration risk and accelerate design readinessSUNNYVALE, Calif.,
More news about: Synopsys, Inc.
Jul 27, 2026, 08:44 ET Repurchase Truecaller B shares in week 30, 2026 and exceeding threshold for holding of own shares
July 27, 2026 /PRNewswire/ -- During week 30, 20 July - 24 July 2026, Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) repurchased in total 5,270,000 own B shares (ISIN: SE0016787071), corresponding to 1.56% of outstanding capital. Furthermore, it is announced
More news about: Truecaller AB
Jul 27, 2026, 08:41 ET RKD Group Acquires Whiteboard
engagement to help these companies enable impact at scale. Together, RKD Group and Whiteboard will offer its collective client roster, which includes Susan G. Komen, The Salvation Army, The Pancreatic Cancer Action Network, and more, a robust suite of creative, branding, and digital capabilities."In
More news about: RKD Group
Jul 27, 2026, 08:01 ET From Wrong Answers to Wrong Actions: The New Risk of Agentic AI in Life Sciences
https://macg.ai.References:Asaftei, G. M., Roberts, R., Sticha, A., & Prinsen, C. (2026, March 25). State of AI trust in 2026: Shifting to the agentic era. McKinsey & Company. mck
More news about: AINGENS
Jul 27, 2026, 08:00 ET HIGH LINER FOODS' SEA CUISINE® EXPANDS THE FROZEN AISLE WITH NEW SKILLET MEALS
Mediterranean-Style Sole Pasta (22g of protein per serving) Sea Cuisine's wild-caught sole paired with penne pasta, roasted yellow and red peppers, and diced tomatoes in a Mediterranean-inspired lemon caper sauce. Thai Red Curry Salmon (19g of protein per serving) Wild-caught
More news about: High Liner Foods Incorporated
Jul 27, 2026, 07:33 ET 100 Days from the 2026 Midterms, When We All Vote Bets on Community and Welcomes Marsai Martin and Victoria Monét as Co-Chairs
gap, and change the culture around voting.Michelle Obama founded When We All Vote in 2018 and is joined by fellow Co-Chairs Stephen Curry, Becky G, Selena Gomez, Tom Hanks, H.E.R., Liza Koshy, Jennifer Lopez, Lin-Manuel Miranda, Janelle Monáe, Chris Paul, Megan Rapinoe, Shonda Rhimes, Bretman Rock,
More news about: When We All Vote
Jul 27, 2026, 06:24 ET Anta Scaffolding Selected to Support Al Maktoum International Airport Project, Strengthening Local Delivery Through Dubai Office
https://www.antascaffolding.com/ Dubai Office Address: Dubai, Internal City, Indigo Spectrum 2, G05, +971 50 286 3788Saudi Office Address: Saudi, Dammam, +966546076255China Office Address: 2/F, Building 4, Ruikang Science and Technology
More news about: Suzhou Anta Scaffolding Engineering Co., Ltd.
Jul 27, 2026, 06:00 ET IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates Part 2 Monotherapy Expansion in the Phase 1/2 Study in MTAP-Deleted Pancreatic and Lung Cancers
intended to maximize its therapeutic window, and favorable drug-like properties to enable rational combinations with IDE397, pan-RAS inhibitors, KRAS G12D therapies, and IDEAYA's CDKN2A lead molecule. IDE892 has a CYP3A4 IC50 greater than 45 micromolar and did not show time dependent inhibition of any
More news about: IDEAYA Biosciences, Inc.
Jul 27, 2026, 03:46 ET 슈퍼마이크로, 6세대 AMD EPYC 9006 시리즈 CPU 기반 신규 서버 포트폴리오 출시…세대 간 최대 1.7배 성능 향상
캘리포니아주 산호세, 2026년 7월 27일 /PRNewswire/ -- AI, 엔터프라이즈, 스토리지 및 5G/엣지를 위한 토탈 IT 솔루션을 제공하며 데이터센터 빌딩 블록 솔루션®(Data Center Building Block Solutions; DCBBS)을 보유한 슈퍼마이크로컴퓨터(Super Micro Computer, Inc.(SMCI), 이하 슈퍼마이크로)가 6세대
More news about: Super Micro Computer, Inc.
Jul 27, 2026, 02:53 ET Beijing Review: Young People from China and U.S. Gather in Kunming: Exploring Rural Development, Enhancing Friendly Exchange
https://x.com/beijingreview/status/2078440724844909034?s=46&t=yfVMVdMyE2zKAFrYaLoV-gFacebook: https://www.facebook.com/share/v/1H3zDf4u3B/?mibextid=wwXIfr
More news about: Beijing Review
Jul 26, 2026, 23:35 ET Ookla Study in Manila: Carrier VoLTE Networks Prove to Outperform OTT Apps in Voice Quality and Reliability
OTT's best-effort data model.The Path Forward: Building a Solid VoLTE Foundation for AI-Driven VoiceAs Philippine NTC mandates the 3G sunset by December 2026, the industry must prioritize comprehensive VoLTE coverage and user migration. Looking ahead, the convergence of voice and AI
More news about: Ookla
Jul 25, 2026, 15:14 ET Nova Biomedical breidt geïntegreerde workflows voor de ontwikkeling van cellijnen uit: NanoCellect-producten maken nu deel uit van Nova Biomedical
het zijn vermogen om biofarmaceutische workflows te ondersteunen, van de vroege ontwikkelingsfase tot en met de productie.Het NanoCellect® WOLF G2®-platform voor celsortering introduceert een zachte, op microfluïdica gebaseerde methode voor celselectie en -isolatie en vormt een aanvulling op Nova
More news about: Nova Biomedical
Jul 25, 2026, 15:11 ET Nova Biomedical 完善整合式細胞株開發流程：NanoCellect 產品線正式加盟 Nova Biomedical
今日宣佈，已落實收購微流體細胞分選技術供應商 NanoCellect 的部分資產。 此項交易大幅擴展了 Nova Biomedical 在細胞株開發領域的實力，並進一步鞏固其支援由早期研發至量產等各階段生物製藥工作流程的能力。NanoCellect® WOLF G2® 細胞分選平台採用溫和的微流體細胞篩選與分離技術，與 Nova Biomedical 旗下現有應用於克隆生成、驗證及生長分析的 Solentim 產品組合相輔相成。兩項技術結合後，將為細胞株開發帶來一套更全面的整合方案——無縫串連細胞篩選、單細胞分離及高準確度克隆驗證。Nova
More news about: Nova Biomedical
Jul 25, 2026, 15:11 ET Nova Biomedical、細胞株開発の統合ワークフローを推進：NanoCellect製品がNova Biomedicalに加わる
これにより、Nova Biomedicalは細胞株開発における対応力を高めるとともに、初期開発から製造に至るバイオ医薬品ワークフローへの支援を強化します。NanoCellect® WOLF G2®細胞選別プラットフォームは、マイクロ流体技術を用い、細胞への負担を抑えた選別・単離を可能にし、クローン作製、検証、増殖解析向けのNova Biomedicalの既存のSolentim製品群を補完します。これらの技術を組み合わせることで、細胞選別、単一細胞単離、信頼性の高いクローン検証を連携させ、細胞株開発をより統合的に進められるようになります。Nova
More news about: Nova Biomedical
Jul 25, 2026, 15:09 ET Nova Biomedical treibt integrierte Arbeitsabläufe für die Zelllinienentwicklung voran: Die Produkte von NanoCellect gehören jetzt zu Nova Biomedical
biopharmazeutische Arbeitsabläufe von der frühen Entwicklung bis hin zur Herstellung zu unterstützen.Die Zellsortierplattform NanoCellect® WOLF G2® ermöglicht eine schonende, mikrofluidische Zellselektion und -isolierung und ergänzt das bestehende Solentim-Portfolio von Nova Biomedical für
More news about: Nova Biomedical
Jul 25, 2026, 03:15 ET Beijing Review: Walking Through Time: China and U.S. Youths Explore Dali's Past and Future
https://x.com/beijingreview/status/2080104404552663067?s=46&t=yfVMVdMyE2zKAFrYaLoV-ghttps://www.facebook.com/share/v/1EtGCCKzy4/?mibextid=wwXIfr
More news about: Beijing Review
Jul 24, 2026, 20:20 ET Greenberg Traurig, Attorneys Shortlisted for 2026 LMG Life Sciences Americas Awards
Lori G. Cohen, Litigation & Enforcement: Product Liability Attorney of the Year
More news about: Greenberg Traurig, LLP
Jul 24, 2026, 15:42 ET Lucid Group, Inc. (LCID) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
IN LUCID GROUP, INC. (LCID), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE JULY 28, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at
More news about: Law Offices of Howard G. Smith
Jul 24, 2026, 15:34 ET Intuit Inc. (INTU) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOSS IN INTUIT INC. (INTU), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE SEPTEMBER 8, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at
More news about: Law Offices of Howard G. Smith
Jul 24, 2026, 15:33 ET Via Transportation, Inc. (VIA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
TRANSPORTATION, INC. (VIA), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE AUGUST 10, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at
More news about: Law Offices of Howard G. Smith
Jul 24, 2026, 15:31 ET Erasca, Inc. (ERAS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOSS IN ERASCA, INC. (ERAS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE AUGUST 10, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at
More news about: Law Offices of Howard G. Smith
Jul 24, 2026, 15:31 ET Hub Group, Inc. (HUBG) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
IN HUB GROUP, INC. (HUBG), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE AUGUST 28, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at
More news about: Law Offices of Howard G. Smith
Jul 24, 2026, 14:07 ET A Nova Biomedical Advances implementa fluxos de trabalho integrados voltados ao desenvolvimento de linhagens celulares: Os produtos da NanoCellect agora fazem parte do portfólio da Nova Biomedical
trabalho biofarmacêuticos, das etapas iniciais de desenvolvimento à fabricação.A plataforma de triagem celular NanoCellect® WOLF G2® oferece seleção e isolamento de células de forma delicada, por meio de tecnologia microfluídica, complementando o portfólio já consolidado da Solentim,
More news about: Nova Biomedical